Cancer

Scientists and clinicians discussed their solutions for overcoming the challenge of getting past the blood-brain barrier in DDN’s first seminar.

Researchers face more obstacles studying the lung microbiome than the gut microbiome. One big hurdle is collecting lung samples. In a new study, researchers used an invasive technique to collect fluid from children’s lungs and discovered how the lung’s microbial makeup affects stem cell transplant outcomes.

Researchers no longer think that proteins blindly swim through the cytoplasm hoping to bump into one another. Instead, they intentionally aggregate with other biomolecules, forming membrane free, transient organelles called condensates.

Scientists discovered that healthy epithelial cells recognize their precancerous neighbors via the expression of proteins normally only found on immune cells. The proteins that mediate this recognition between healthy and precancerous cells provide a potential new therapeutic avenue for treating cancer.

There are now more cancer treatment options than ever before. However, almost all of them face the same major challenge: eventually, they stop working. There are several unique ways in which cancer cells evade death. Now, scientists are inventing new technologies to target these mechanisms and overcome resistance.

Biomedical engineer Natasha Sheybani uses soundwaves to disrupt the blood-brain barrier and improve immunotherapy for glioblastoma patients.

Scientists fight against cancer progression using checkpoint inhibitor drugs.

LIVE March 29th, 2022 at 2:30 PM
Proteolysis targeting chimeras (PROTACs) are promising agents for developing novel anticancer drugs.

A hormone only discussed among specialized scientists is making a big splash in the ovarian health field. It may soon become a household name.

In children, T cells effectively combat acute infections such as COVID-19, but a new study in mice suggests that the T cell response is detrimental when fighting pediatric tumors.